Clinical Trials Logo

Breast Neoplasm, Male clinical trials

View clinical trials related to Breast Neoplasm, Male.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02950259 Active, not recruiting - Clinical trials for Triple Negative Breast Cancer

Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

Start date: February 9, 2017
Phase: Phase 1
Study type: Interventional

The goal of this study is assess the safety and tolerability of the IRX-2 regimen in patients with early stage breast cancer (ESBC) and to estimate the pathologic complete response rate to neoadjuvant anthracycline-based and non-platinum containing chemotherapy in patients with triple-negative breast cancer who have received the IRX-2 Regimen before chemotherapy.